Barclays PLC Ginkgo Bioworks Holdings, Inc. Transaction History

Barclays PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.28 - $1.16 $69,744 - $288,940	-249,087 Reduced 64.37%	137,873 $46,000
Q1 2024 May 15, 2024	BUY	$1.06 - $1.67 $19,388 - $30,545	18,291 Added 4.96%	386,960 $448,000
Q4 2023 Feb 15, 2024	SELL	$1.26 - $1.79 $8,391 - $11,921	-6,660 Reduced 1.77%	368,669 $622,000
Q3 2023 Nov 07, 2023	BUY	$1.61 - $2.54 $46,944 - $74,061	29,158 Added 8.42%	375,329 $678,000
Q2 2023 Aug 03, 2023	SELL	$1.14 - $1.95 $501,643 - $858,074	-440,038 Reduced 55.97%	346,171 $644,000
Q1 2023 May 04, 2023	SELL	$1.2 - $2.19 $104,509 - $190,729	-87,091 Reduced 9.97%	786,209 $1.05 Million
Q4 2022 Feb 13, 2023	BUY	$1.63 - $3.52 $179,547 - $387,735	110,152 Added 14.43%	873,300 $1.48 Million
Q3 2022 Nov 03, 2022	BUY	$0.73 - $3.74 $332,874 - $1.71 Million	455,993 Added 148.46%	763,148 $2.38 Million
Q2 2022 Aug 12, 2022	BUY	$2.2 - $4.2 $589,017 - $1.12 Million	267,735 Added 679.19%	307,155 $731,000
Q1 2022 May 16, 2022	BUY	$2.83 - $8.69 $111,558 - $342,559	39,420 New	39,420 $159,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.